Search

Your search keyword '"Trombetta, C"' showing total 103 results
Start Over Author "Trombetta, C" Publication Year Range Last 3 years
103 results on '"Trombetta, C"'

1. Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination

Author

Riccomi, A., primary, Trombetta, C. M., additional, Dorrucci, M., additional, Di Placido, D., additional, Sanarico, N., additional, Farchi, F., additional, Giuseppetti, R., additional, Villano, U., additional, Marcantonio, C., additional, Marchi, S., additional, Ciaramella, A., additional, Pezzotti, P., additional, Montomoli, E., additional, Valdarchi, C., additional, Ciccaglione, A. R., additional, and Vendetti, S., additional

Published
2024
Full Text
View/download PDF

2. Diagnostic accuracy of Multiparametric Magnetic Resonance Imaging (mpMRI), targeted and systematic prostate biopsy for the detection of cribriform growth pattern in patients with clinical-localized prostate cancer

Author

Piasentin, A., primary, Rossin, G., additional, Traunero, F., additional, Ongaro, L., additional, Sernaglia, G., additional, Biasatti, A., additional, Rizzo, M., additional, Zucchi, A., additional, Bartoletti, R., additional, Liguori, G., additional, Bertolotto, M., additional, Trombetta, C., additional, and Claps, F., additional

Published
2024
Full Text
View/download PDF

3. EAU Risk stratification for prostate cancer according to systematic biopsy, target biopsy and combined biopsy results and final pathology concordance. Results from the PROMOD study group

Author

Ninivaggi, A., primary, Falagario, U., additional, Cormio, A., additional, Galosi, A., additional, Carmignani, L., additional, Montanari, E., additional, Bove, P., additional, Gontero, P., additional, Porpiglia, F., additional, Sciarra, A., additional, Trombetta, C., additional, Bassi, P., additional, Simone, G., additional, Ludovico, G., additional, Mirone, V., additional, Antonelli, A., additional, Schips, L., additional, Ricapito, A., additional, Busetto, G.M., additional, Ficarra, V., additional, Boström, P.J., additional, De Cobelli, O., additional, Cormio, L., additional, and Carrieri, G., additional

Published
2024
Full Text
View/download PDF

4. Intercenter variability in the accuracy of risk calculators based on MRI parameters: Extensive external validation of 7 contemporary risk calculators

Author

Tocci, E., primary, Falagario, U., additional, Lantz, A., additional, Carmignani, L., additional, Montanari, E., additional, Bove, P., additional, Gontero, P., additional, Porpiglia, F., additional, Sciarra, A., additional, Trombetta, C., additional, Bassi, P., additional, Simone, G., additional, Mirone, V., additional, Antonelli, A., additional, Schips, L., additional, Ludovico, G., additional, Ricapito, A., additional, Busetto, G., additional, Ficarra, V., additional, Bostrom, P., additional, De Cobelli, O., additional, Nordstrom, T., additional, Cormio, L., additional, and Carrieri, G., additional

Published
2024
Full Text
View/download PDF

5. Impact of magnetic resonance imaging scan and image acquisition protocol in detecting clinically significant prostate cancer at biopsy: Results from the PROMOD working group

Author

Fanelli, A., primary, Finati, M., additional, Falagario, U.G., additional, Lantz, A., additional, Jambor, I., additional, Carmignani, L., additional, Montanari, E., additional, Bove, P., additional, Gontero, P., additional, Sciarra, A., additional, Trombetta, C., additional, Bassi, P., additional, Simone, G., additional, Mirone, V., additional, Antonelli, A., additional, Schips, L., additional, Busetto, G.M., additional, Bettocchi, C., additional, Ferro, M., additional, Bostrom, P., additional, Nordstrom, T., additional, De Cobelli, O., additional, Cormio, L., additional, and Carrieri, G., additional

Published
2024
Full Text
View/download PDF

6. Perioperative and long-term oncological outcomes after local tumor ablation for complex (PADUA Score =10) cT1a renal tumors: a multicenter analysis

Author

Piazza, P., primary, Bianchi, L., additional, Luzzago, S., additional, Bandini, M., additional, Mottaran, A., additional, Amirhassankhani, S., additional, De Concilio, B., additional, Celia, A., additional, Serra, C., additional, Cappelli, A., additional, Golfieri, R., additional, Musi, G., additional, Gallina, A., additional, Rizzo, M., additional, Liguori, G., additional, Trombetta, C., additional, De Cobelli, F., additional, Mauri, G., additional, Orsi, F., additional, Capitanio, U., additional, Schiavina, R., additional, De Cobelli, O., additional, Montorsi, F., additional, and Brunocilla, E., additional

Published
2023
Full Text
View/download PDF

10. A RANDOMIZED CONTROLLED TRIAL ON THE EFFICACY OF BINAURAL BEATS IN REDUCING ANXIETY AND PAIN LEVELS IN PATIENTS UNDERGOING CONVENTIONAL URODYNAMIC STUDY. PRELIMINARY DATA AND PERSPECTIVES.

Author

Vedovo, F, primary, Leonardo Martini, J, additional, Morreale, C, additional, Balzarro, M, additional, Rubilotta, E, additional, Marini, M, additional, Gubbiotti, M, additional, Giommoni, V, additional, Capogrosso, P, additional, Di Blas, L, additional, and Trombetta, C, additional

Published
2023
Full Text
View/download PDF

12. Sexual outcomes in men who have sex with men who underwent radical prostatectomy

Author

Vedovo, F., Lonati, C., Suardi, N., Mariani, L., Capogrosso, P., Ficarra, V., Salonia, A., and Trombetta, C.

Abstract

Background: Sexual difficulties are a recognized consequence of prostate cancer (PCa) treatments. An estimated one in three men who have sex with men (MSM) receive PCa a diagnosis during their lifetime. MSM may experience all types of sexual dysfunction as reported in men who have sex with women (MSW), along with a number of more specific bothersome problems. This systematic literature review aims to evaluate sexual outcomes in MSM who have undergone radical prostatectomy (RP). Methods: A systematic review was carried out following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The searches were made using relevant keywords in the PubMed, Scopus, and Web of Science databases, thus including the whole literature from January 2000 to November 2023. Studies which did not allow to retrieve data on sexual outcomes on MSM treated with RP for PCa were excluded. Data on sexual outcomes and health-related quality of life (HRQoL) were retrieved, mostly including changes in libido, erectile function, ejaculatory disorders, orgasm, climacturia, changes in role-in-sex identity, changes in sexual partnerships, and the presence of painful receptive anal intercourses (AI). PROSPERO ID: CRD42024502592. Results: Six articles met the inclusion criteria. In total, data of 260 patients were analyzed. Three main themes emerged: (a) MSM may experience specific sexual dysfunctions due to the different dynamics of their intimacy; (b) the lack of tool validated on gay and bisexual population to assess sexual outcomes (c) the need for a tailored approach that also takes into account sexual orientation throughout the oncological journey. Conclusions: MSM undergoing RP may experience similar sexual problems as MSW. Painful AI should be considered a potential post-operative adverse outcome in MSM. Future studies should prioritize validating a questionnaire that explores AI. Healthcare providers should adopt a tailored approach that takes into account sexual orientation throughout the cancer journey.

Published
2024
Full Text
View/download PDF

13. Survival after radical prostatectomy vs. radiation therapy in clinical node positive prostate cancer patients: A multicentric study

Author

Chierigo, F., primary, Scaffidi, C., additional, Porcaro, A., additional, Amparore, D., additional, Bertolo, R., additional, Bravi, C.A., additional, Bozzini, G., additional, Trombetta, C., additional, Mearini, E., additional, Montanari, E., additional, Ditonno, P., additional, Simonato, A., additional, Bove, P., additional, De Nunzio, C., additional, Tubaro, A., additional, Schiavina, R., additional, Brunocilla, E., additional, Antonelli, A., additional, Galosi, A., additional, Mottrie, A., additional, Porpiglia, F., additional, Barra, S., additional, Borghesi, M., additional, and Terrone, C., additional

Published
2023
Full Text
View/download PDF

16. Percutaneous microwave ablation has similar perioperative and oncologic outcomes than cryoablation for the treatment of T1a renal masses: results from a cross-sectional study

Author

Lucignani, G., primary, Boeri, L., additional, Ierardi, A.M., additional, Piasentin, A., additional, Trombetta, C., additional, De Lorenzis, E., additional, Liguori, G., additional, Bertolotto, M., additional, Rizzo, M., additional, Carrafiello, G., additional, and Montanari, E., additional

Published
2022
Full Text
View/download PDF

17. Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (radical nephroureterectomy outcomes (RANEO) research consortium)

Author

Tafuri, A., primary, Marchioni, M., additional, Cerrato, C., additional, Mari, A., additional, Tellini, R., additional, Odorizzi, K., additional, Veccia, A., additional, Amparore, D., additional, Shakir, A., additional, Carbonara, U., additional, Trovato, F., additional, Catellani, M., additional, Janello, L.M.I., additional, Bianchi, L., additional, Novara, G., additional, Dal Moro, F., additional, Schiavina, R., additional, De Lorenzis, E., additional, Parma, P., additional, Cimino, S., additional, de Cobelli, O., additional, Maiorino, F., additional, Bove, P., additional, Crocerossa, F., additional, Cantiello, F., additional, D’andrea, D., additional, Di Cosmo, F., additional, Porpiglia, F., additional, Ditonno, P., additional, Montanari, E., additional, Soria, F., additional, Gontero, P., additional, Liguori, G., additional, Trombetta, C., additional, Mantica, G., additional, Borghesi, M., additional, Terrone, C., additional, Del Giudice, F., additional, Sciarra, A., additional, Galosi, A., additional, Moschini, M., additional, Shariat, S.F., additional, Di Nicola, M., additional, Minervini, A., additional, Ferro, M., additional, Cerruto, M.A., additional, Schips, L., additional, Pagliarulo, V., additional, and Antonelli, A., additional

Published
2022
Full Text
View/download PDF

19. Peyronie’s disease questionnaire: PDQ-I italian validation

Author

Liguori, G., primary, Di Grazia, M., additional, Pellizzoni, S., additional, Ongaro, L., additional, Cocci, A., additional, Verze, P., additional, Cai, T., additional, Zucchi, A., additional, Vedovo, F., additional, Rizzo, M., additional, Garaffa, G., additional, and Trombetta, C., additional

Published
2022
Full Text
View/download PDF

20. Predictors of residual tumor at re-staging transurethral resection for high-risk non-muscle invasive bladder cancer: insights from a large multi-institutional collaboration

Author

Claps, F., primary, Pavan, N., additional, d’Altilia, N., additional, Maggi, M., additional, Checcucci, E., additional, Napolitano, L., additional, Morlacco, A., additional, Tafuri, A., additional, Palumbo, C., additional, Mazzon, G., additional, Del Giudice, F., additional, Campi, R., additional, Signorini, C., additional, Boeri, L., additional, Giannarini, G., additional, Esperto, F., additional, Tulone, G., additional, Finati, M., additional, Sica, M., additional, La Rocca, R., additional, Bignù, C., additional, Celentano, G., additional, Falagario, U., additional, Traunero, F., additional, Panunzio, A., additional, Zucchi, A., additional, Sciarra, A., additional, Liguori, G., additional, Busetto, G.M., additional, Bartoletti, R., additional, Simonato, A., additional, Minervini, A., additional, Papalia, R., additional, Scarpa, R.M., additional, Serni, S., additional, Montanari, E., additional, Carmignani, L., additional, Celia, A., additional, Volpe, A., additional, Antonelli, A., additional, Dal Moro, F., additional, Mirone, V., additional, Porpiglia, F., additional, Tubaro, A., additional, Cormio, L., additional, Carrieri, G., additional, and Trombetta, C., additional

Published
2022
Full Text
View/download PDF

21. Antibacterial rifampicin-loaded electrospun polycaprolactone membranes for ureteral regeneration

Author

Musciacchio, L., Mardirossian, M., Guagnini, B., Raffini, A., Rizzo, M., Trombetta, C., Liguori, G., Ongaro, L., Turco, G., Porrelli, D., Musciacchio, L., Mardirossian, M., Guagnini, B., Raffini, A., Rizzo, M., Trombetta, C., Liguori, G., Ongaro, L., Turco, G., and Porrelli, D.

Subjects
antibacterial, ureteral regeneration, biomaterial, electrospinning, polycaprolactone, rifampicin, Urology
Abstract

Author of the study: Nowadays partial or complete ureteral loss following resection or injuries of various etiology is managed with different surgical techniques involving local tissue flaps or autologous tissues interposition. In the last years ureteral tissue engineering using membranes, tubular scaffolds or decellularized matrices has shown promising results for ureteral substitution. The aim of this study is to evaluate the use of antibacterial electrospun polycaprolactone/ rifampicin (PCL/RIF) membranes for the production of ureteral scaffolds with antibacterial properties. Materials and methods: Electrospinning processwas used to produce the membranes that were subsequently impregnated with rifampicin. Membranes stability was evaluated by immersion in Simulated Body Fluid (SBF) at 37 °C. Mechanical properties were evaluated by uniaxial tensile tests, Young’s modulus was calculated for each sample. UV spectrophotometry was used to evaluate in vitro release of rifampicin. The ability of PCL/Rif membranes to sustain cell adhesion and proliferation was evaluated by seeding human urothelial bladder carcinoma cells on the membranes. In order to investigate the antibacterial effect of PCL/Rif membranes, in vitro antibacterial tests were performed using bacterial strains belonging to the “ESKAPE” group. Results: PCL/Rif membranes are characterized by a random distribution of fibers with an average diameter of 0.52 μm.Water contact angle for PCL and PCL/Rif membranes is around 125° and decreases to 0° after air-plasma treatment. When culture medium is used as testing fluid PCL and PCL/Rif contact angles are 116° and 12° respectively. Membranes are deformable up to 300% of their initial dimension and possess an elastic Young modulus of about 20 kPa; after 3 weeks membranes gain the property to sustain a 100% deformation before rupture. The 72% of rifampicin load is released by the membranes in the first 24 hours. Proliferation assay showed a seven-fold increase of cell number adhered on the membranes after 7 days of culture. At the same time in presence of PCL/Rif membranes, rates of bacterial proliferation inhibition ranged from 75 to 94% compared to controls. Conclusions: PCL/Rif membranes represent a promising starting point in the production of ureteral scaffolds with antibacterial properties for ureteral substitution.

Published
2022

22. Re: Toward Individualized Approaches to Partial Nephrectomy: Assessing the Correlation between Ischemia Time and Patient Health Status (RECORD2 Project)

Author

Bravi C. A., Mari A., Larcher A., Amparore D., Antonelli A., Artibani W., Bertini R., Bove P., Brunocilla E. U., Da Pozzo L., Di Maida F., Fiori C., Gallioli A., Gontero P., Marzi V. L., Longo N., Mirone V., Porpiglia F., Rocco B., Schiavina R., Schips L., Simeone C., Siracusano S., Tellini R., Terrone C., Trombetta C., Ficarra V., Carini M., Montorsi F., Capitanio U., Minervini A., Bravi, C. A., Mari, A., Larcher, A., Amparore, D., Antonelli, A., Artibani, W., Bertini, R., Bove, P., Brunocilla, E. U., Da Pozzo, L., Di Maida, F., Fiori, C., Gallioli, A., Gontero, P., Marzi, V. L., Longo, N., Mirone, V., Porpiglia, F., Rocco, B., Schiavina, R., Schips, L., Simeone, C., Siracusano, S., Tellini, R., Terrone, C., Trombetta, C., Ficarra, V., Carini, M., Montorsi, F., Capitanio, U., and Minervini, A.

Subjects
Retroperitoneal Neoplasm, Humans, Kidney, Medical Oncology, Retroperitoneal Neoplasms, Ureter, Urology, Human
Abstract

Not applicable

Published
2022

24. Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0

Author

Calabro, G. E., Boccalini, S., Bechini, A., Panatto, D., Domnich, A., Lai, P. L., Amicizia, D., Rizzo, C., Pugliese, A., DI Pietro, M. L., Zanella, B., Parente, F., Trombetta, C. S., Saraceno, G., Sottile, S., Abreha, F. M., Giacchetta, I., Properzi, S., Santolini, G., D'Ambrosio, F., Maida, A., Scardigno, A., LA Gatta, E., Petrella, L., Bonanni, P., and DE Waure, C.

Published
2022

26. The adding value of COntrolling NUTritional status (CONUT) score to pre-operative counselling on significant early loss of renal function after radical nephrectomy for cancer

Author

Ongaro, L., primary, Boltri, M., additional, Claps, F., additional, Vianello, F., additional, Lenardon, O., additional, Visalli, F., additional, Buttazzi, L., additional, Maruzzi, D., additional, Migliozzi, F., additional, Pavan, N., additional, Liguori, G., additional, and Trombetta, C., additional

Published
2022
Full Text
View/download PDF

28. Laparoscopic versus robotic partial nephrectomy in obese patients: Perioperative and early functional outcomes from a large contemporary series (RECORD2 project)

Author

Tellini, R., primary, Mari, A., additional, Antonelli, A., additional, Lambertini, L., additional, Bove, P., additional, Brunocilla, E., additional, Capitanio, U., additional, Checcucci, E., additional, Di Maida, F., additional, Gontero, P., additional, Longo, N., additional, Montorsi, F., additional, Porpiglia, F., additional, Porreca, A., additional, Rocco, B., additional, Schiavina, R., additional, Serni, S., additional, Simeone, C., additional, Trombetta, C., additional, Ficarra, V., additional, Carini, M., additional, and Minervini, A., additional

Published
2022
Full Text
View/download PDF

29. Diagnosis of prostate cancer in men treated with 5-alpha-reducates inhibitors with multi-parametric MRI: Results of a multicenter international collaboration

Author

Falagario, U.G., primary, Lantz, A., additional, Jambor, I., additional, Busetto, G.M., additional, Carmignani, L., additional, Montanari, E., additional, Bove, P., additional, Gontero, P., additional, Sciarra, A., additional, Di Tonno, P., additional, Trombetta, C., additional, Bassi, P., additional, Simone, G., additional, Mirone, V., additional, Antonelli, A., additional, Schips, L., additional, Bostrom, P., additional, Porpiglia, F., additional, Nordström, T., additional, De Cobelli, O., additional, Cormio, L., additional, Carrieri, G., additional, and Ferro, M., additional

Published
2022
Full Text
View/download PDF

30. The effect of COVID-19 outbreak on endourological treatments for urinary stones: A retrospective multicentric study

Author

Mazzon, G., primary, Ferretti, S., additional, Acquati, P., additional, Nazzani, S., additional, Campobasso, D., additional, Germinale, F., additional, Filippi, B., additional, Micali, S., additional, Pavan, N., additional, De Marco, G., additional, Vismara Fugini, A., additional, Morena, T., additional, Peroni, A., additional, Celentano, G., additional, Creta, M., additional, Serafin, E., additional, Costa, G., additional, Rocco, B., additional, Maestrani, U., additional, Vaccaro, C., additional, Carmignani, L., additional, Trombetta, C., additional, Cerruto, M.A., additional, Antonelli, A., additional, and Celia, A., additional

Published
2022
Full Text
View/download PDF

31. Renal function variation after nephroureterectomy for upper urinary tract carcinoma: Evaluation in a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)

Author

Tafuri, A., primary, Marchioni, M., additional, Cerrato, C., additional, Mari, A., additional, Veccia, A., additional, Parma, P., additional, Dal Moro, F., additional, Schiavina, R., additional, Bove, P., additional, Cantiello, F., additional, Porpiglia, F., additional, Ditonno, P., additional, Montanari, E., additional, Gontero, P., additional, Trombetta, C., additional, Terrone, C., additional, Schips, L., additional, Sciarra, A., additional, Galosi, A., additional, Ferro, M., additional, Shariat, S.F., additional, Di Nicola, M., additional, Minervini, A., additional, Pagliarulo, V., additional, and Antonelli, A., additional

Published
2022
Full Text
View/download PDF

32. Diagnosis of prostate cancer in men treated with 5-alpha-reducates inhibitors with multi-parametric MRI: Results of a multicenter international collaboration

Author

ugo falagario, Lantz, A., Jambor, I., Busetto, G. M., Carmignani, L., Montanari, E., Bove, P., Gontero, P., Sciarra, A., Di Tonno, P., Trombetta, C., Bassi, P., Simone, G., Mirone, V., Antonelli, A., Schips, L., Bostrom, P., Porpiglia, F., T, Nordstrom, Cobelli, O., Cormio, L., Carrieri, G., and Ferro, M.

Subjects
Urology
Published
2022

33. P172 - Perioperative and long-term oncological outcomes after local tumor ablation for complex (PADUA Score =10) cT1a renal tumors: a multicenter analysis

Author

Piazza, P., Bianchi, L., Luzzago, S., Bandini, M., Mottaran, A., Amirhassankhani, S., De Concilio, B., Celia, A., Serra, C., Cappelli, A., Golfieri, R., Musi, G., Gallina, A., Rizzo, M., Liguori, G., Trombetta, C., De Cobelli, F., Mauri, G., Orsi, F., Capitanio, U., Schiavina, R., De Cobelli, O., Montorsi, F., and Brunocilla, E.

Published
2023
Full Text
View/download PDF

34. SC223 - Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (radical nephroureterectomy outcomes (RANEO) research consortium)

Author

Tafuri, A., Marchioni, M., Cerrato, C., Mari, A., Tellini, R., Odorizzi, K., Veccia, A., Amparore, D., Shakir, A., Carbonara, U., Trovato, F., Catellani, M., Janello, L.M.I., Bianchi, L., Novara, G., Dal Moro, F., Schiavina, R., De Lorenzis, E., Parma, P., Cimino, S., de Cobelli, O., Maiorino, F., Bove, P., Crocerossa, F., Cantiello, F., D’andrea, D., Di Cosmo, F., Porpiglia, F., Ditonno, P., Montanari, E., Soria, F., Gontero, P., Liguori, G., Trombetta, C., Mantica, G., Borghesi, M., Terrone, C., Del Giudice, F., Sciarra, A., Galosi, A., Moschini, M., Shariat, S.F., Di Nicola, M., Minervini, A., Ferro, M., Cerruto, M.A., Schips, L., Pagliarulo, V., and Antonelli, A.

Published
2022
Full Text
View/download PDF

35. SC220 - Predictors of residual tumor at re-staging transurethral resection for high-risk non-muscle invasive bladder cancer: insights from a large multi-institutional collaboration

Author

Claps, F., Pavan, N., d’Altilia, N., Maggi, M., Checcucci, E., Napolitano, L., Morlacco, A., Tafuri, A., Palumbo, C., Mazzon, G., Del Giudice, F., Campi, R., Signorini, C., Boeri, L., Giannarini, G., Esperto, F., Tulone, G., Finati, M., Sica, M., La Rocca, R., Bignù, C., Celentano, G., Falagario, U., Traunero, F., Panunzio, A., Zucchi, A., Sciarra, A., Liguori, G., Busetto, G.M., Bartoletti, R., Simonato, A., Minervini, A., Papalia, R., Scarpa, R.M., Serni, S., Montanari, E., Carmignani, L., Celia, A., Volpe, A., Antonelli, A., Dal Moro, F., Mirone, V., Porpiglia, F., Tubaro, A., Cormio, L., Carrieri, G., and Trombetta, C.

Published
2022
Full Text
View/download PDF

43. A0717 - EAU Risk stratification for prostate cancer according to systematic biopsy, target biopsy and combined biopsy results and final pathology concordance. Results from the PROMOD study group.

Author

Ninivaggi, A., Falagario, U., Cormio, A., Galosi, A., Carmignani, L., Montanari, E., Bove, P., Gontero, P., Porpiglia, F., Sciarra, A., Trombetta, C., Bassi, P., Simone, G., Ludovico, G., Mirone, V., Antonelli, A., Schips, L., Ricapito, A., Busetto, G.M., and Ficarra, V.

Subjects
*BIOPSY, *PATHOLOGY, *PROSTATE cancer
Published
2024
Full Text
View/download PDF

44. P324 - Impact of magnetic resonance imaging scan and image acquisition protocol in detecting clinically significant prostate cancer at biopsy: Results from the PROMOD working group.

Author

Fanelli, A., Finati, M., Falagario, U.G., Lantz, A., Jambor, I., Carmignani, L., Montanari, E., Bove, P., Gontero, P., Sciarra, A., Trombetta, C., Bassi, P., Simone, G., Mirone, V., Antonelli, A., Schips, L., Busetto, G.M., Bettocchi, C., Ferro, M., and Bostrom, P.

Subjects
*MAGNETIC resonance imaging, *PROSTATE biopsy, *PROSTATE cancer
Published
2024
Full Text
View/download PDF

45. A0711 - Intercenter variability in the accuracy of risk calculators based on MRI parameters: Extensive external validation of 7 contemporary risk calculators.

Author

Tocci, E., Falagario, U., Lantz, A., Carmignani, L., Montanari, E., Bove, P., Gontero, P., Porpiglia, F., Sciarra, A., Trombetta, C., Bassi, P., Simone, G., Mirone, V., Antonelli, A., Schips, L., Ludovico, G., Ricapito, A., Busetto, G., Ficarra, V., and Bostrom, P.

Subjects
*CALCULATORS, *MAGNETIC resonance imaging
Published
2024
Full Text
View/download PDF

46. A0064 - Diagnostic accuracy of Multiparametric Magnetic Resonance Imaging (mpMRI), targeted and systematic prostate biopsy for the detection of cribriform growth pattern in patients with clinical-localized prostate cancer.

Author

Piasentin, A., Rossin, G., Traunero, F., Ongaro, L., Sernaglia, G., Biasatti, A., Rizzo, M., Zucchi, A., Bartoletti, R., Liguori, G., Bertolotto, M., Trombetta, C., and Claps, F.

Subjects
*MAGNETIC resonance imaging, *PROSTATE cancer patients, *PROSTATE biopsy, *PROSTATE cancer
Published
2024
Full Text
View/download PDF

48. Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)

Author

Alessandro Tafuri, Michele Marchioni, Clara Cerrato, Andrea Mari, Riccardo Tellini, Katia Odorizzi, Alessandro Veccia, Daniele Amparore, Aliasger Shakir, Umberto Carbonara, Andrea Panunzio, Federica Trovato, Michele Catellani, Letizia M. I. Janello, Lorenzo Bianchi, Giacomo Novara, Fabrizio Dal Moro, Riccardo Schiavina, Elisa De Lorenzis, Paolo Parma, Sebastiano Cimino, Ottavio De Cobelli, Francesco Maiorino, Pierluigi Bove, Fabio Crocerossa, Francesco Cantiello, David D’Andrea, Federica Di Cosmo, Francesco Porpiglia, Pasquale Ditonno, Emanuele Montanari, Francesco Soria, Paolo Gontero, Giovanni Liguori, Carlo Trombetta, Guglielmo Mantica, Marco Borghesi, Carlo Terrone, Francesco Del Giudice, Alessandro Sciarra, Andrea Galosi, Marco Moschini, Shahrokh F. Shariat, Marta Di Nicola, Andrea Minervini, Matteo Ferro, Maria Angela Cerruto, Luigi Schips, Vincenzo Pagliarulo, Alessandro Antonelli, Tafuri, Alessandro, Marchioni, Michele, Cerrato, Clara, Mari, Andrea, Tellini, Riccardo, Odorizzi, Katia, Veccia, Alessandro, Amparore, Daniele, Shakir, Aliasger, Carbonara, Umberto, Panunzio, Andrea, Trovato, Federica, Catellani, Michele, Janello, Letizia M I, Bianchi, Lorenzo, Novara, Giacomo, Dal Moro, Fabrizio, Schiavina, Riccardo, De Lorenzis, Elisa, Parma, Paolo, Cimino, Sebastiano, De Cobelli, Ottavio, Maiorino, Francesco, Bove, Pierluigi, Crocerossa, Fabio, Cantiello, Francesco, D'Andrea, David, Di Cosmo, Federica, Porpiglia, Francesco, Ditonno, Pasquale, Montanari, Emanuele, Soria, Francesco, Gontero, Paolo, Liguori, Giovanni, Trombetta, Carlo, Mantica, Guglielmo, Borghesi, Marco, Terrone, Carlo, Del Giudice, Francesco, Sciarra, Alessandro, Galosi, Andrea, Moschini, Marco, Shariat, Shahrokh F, Di Nicola, Marta, Minervini, Andrea, Ferro, Matteo, Cerruto, Maria Angela, Schips, Luigi, Pagliarulo, Vincenzo, Antonelli, Alessandro, Tafuri A., Marchioni M., Cerrato C., Mari A., Tellini R., Odorizzi K., Veccia A., Amparore D., Shakir A., Carbonara U., Panunzio A., Trovato F., Catellani M., Janello L.M.I., Bianchi L., Novara G., Dal Moro F., Schiavina R., De Lorenzis E., Parma P., Cimino S., De Cobelli O., Maiorino F., Bove P., Crocerossa F., Cantiello F., D'Andrea D., Di Cosmo F., Porpiglia F., Ditonno P., Montanari E., Soria F., Gontero P., Liguori G., Trombetta C., Mantica G., Borghesi M., Terrone C., Del Giudice F., Sciarra A., Galosi A., Moschini M., Shariat S.F., Di Nicola M., Minervini A., Ferro M., Cerruto M.A., Schips L., Pagliarulo V., and Antonelli A.

Subjects
Male, Urologic Neoplasms, Acute Kidney Injury, Chronic Kidney Disease, Radical Nephroureterectomy, Upper tract urothelial carcinoma, Humans, Infant, Nephroureterectomy, Nephrectomy, Glomerular Filtration Rate, Retrospective Studies, Kidney, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urinary Tract, Ureteral Neoplasms, Urology, Retrospective Studie, Upper tract urothelial carcinoma, Radical Nephroureterectomy, Acute Kidney Injury, Chronic Kidney Disease, Carcinoma, Urologic Neoplasm, Urinary Bladder Neoplasm, Transitional Cell, Human
Abstract

Purpose To investigate prevalence and predictors of renal function variation in a multicenter cohort treated with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Methods Patients from 17 tertiary centers were included. Renal function variation was evaluated at postoperative day (POD)—1, 6 and 12 months. Timepoints differences were Δ1 = POD-1 eGFR − baseline eGFR; Δ2 = 6 months eGFR − POD-1 eGFR; Δ3 = 12 months eGFR − 6 months eGFR. We defined POD-1 acute kidney injury (AKI) as an increase in serum creatinine by ≥ 0.3 mg/dl or a 1.5 1.9-fold from baseline. Additionally, a cutoff of 60 ml/min in eGFR was considered to define renal function decline at 6 and 12 months. Logistic regression (LR) and linear mixed (LM) models were used to evaluate the association between clinical factors and eGFR decline and their interaction with follow-up. Results A total of 576 were included, of these 409(71.0%) and 403(70.0%) had an eGFR p p = 0.003), POD-1 AKI (OR 2.88, p p p p = 0.007), POD-1 AKI (OR 1.83, p = 0.02), and preoperative eGFR p p = 0.019), hydronephrosis (p p p = 0.001) influenced renal function variation (ß 9.2 ± 0.7, p Conclusion Age, preoperative eGFR and POD-1 AKI are independent predictors of 6 and 12 months renal function decline after RNU for UTUC.

Published
2022

49. Assessment of Pertussis Underreporting in Italy

Author

Bagordo, Francesco, Grassi, Tiziana, Savio, Marta, Rota, Maria Cristina, Baldovin, Tatjana, Vicentini, Costanza, Napolitano, Francesco, Trombetta, Claudia Maria, Gabutti, Giovanni, Group, Seroepidemiological Study Group Seroepidemiological Study, Bagordo, F., Grassi, T., Savio, M., Rota, M. C., Baldovin, T., Vicentini, C., Napolitano, F., Trombetta, C. M., and Gabutti, G.

Subjects
seroprevalence, pertussis, pertussi, General Medicine, underreporting
Abstract

A study was conducted to assess the degree of pertussis underreporting in Italy. An analysis was performed to compare the frequency of pertussis infections estimated using seroprevalence data with the pertussis incidence based on reported cases among the Italian population. For this purpose, the proportion of subjects who had an anti-PT ≥ 100 IU/mL (indicative of B. pertussis infection within the last 12 months) was compared with the reported incidence rate among the Italian population ≥5 years old, divided into two age groups (6–14 and ≥15 years old), obtained from the European Centre for Disease Prevention and Control (ECDC) database. The pertussis incidence rate in the Italian population ≥5 years old reported by the ECDC in 2018 was 6.75/100,000 in the 5–14 age group and 0.28/100,000 in the ≥15 age group. The proportion of subjects recruited in the present study with an anti-PT ≥ 100 IU/mL was 0.95% in the 6–14 age group and 0.97% in the ≥15 age group. The estimated rate of pertussis infections based on seroprevalence was approximately 141-fold and 3452-fold higher than the reported incidence in the 6–14 age group and in the ≥15 age group, respectively. Quantification of underreporting can allow for the burden of pertussis, as well as the impact of ongoing vaccination, to be better evaluated.

Published
2023
Full Text
View/download PDF

50. Sero-Epidemiological Study of Varicella in the Italian General Population

Author

Gabutti, Giovanni, Grassi, Tiziana, Bagordo, Francesco, Savio, Marta, Rota, Maria Cristina, Castiglia, Paolo, Baldovin, Tatjana, Napolitano, Francesco, Panico, Alessandra, Ogliastro, Matilde, Trombetta, Claudia Maria, Ditommaso, Savina, Tramuto, Fabio, Baldovin, Tatiana, Gabutti G, Grassi T, Bagordo F, Savio M, Rota MC, Castiglia P, Baldovin T, Napolitano F, Panico A, Ogliastro M, Trombetta CM, Ditommaso S, Tramuto F, Sero-Epidemiological Study Group., Gabutti, G., Grassi, T., Bagordo, F., Savio, M., Rota, M. C., Castiglia, P., Baldovin, T., Napolitano, F., Panico, A., Ogliastro, M., Trombetta, C. M., Ditommaso, S., Tramuto, F., Gabutti, Giovanni, Grassi, Tiziana, Bagordo, Francesco, Savio, Marta, cristina rota, Maria, P, Castiglia, Baldovin, Tatjana, Napolitano, Francesco, Panico, Alessandra, Ogliastro, Matilde, Maria Trombetta, Claudia, Ditommaso, Savina, Tramuto, Fabio, and Study Group, Sero-Epidemiological

Subjects
Pharmacology, Infectious Diseases, varicella, Italy, general population, immunization, sero-epidemiology, Drug Discovery, Immunology, Pharmacology (medical), Settore MED/42 - Igiene Generale E Applicata, varicella, sero-epidemiology, Italy, general population, immunization
Abstract

The aim of this study was to analyze the seroprevalence of varicella in Italy and to evaluate the impact of varicella vaccination, which has been mandatory for newborns since 2017. The levels of VZV-specific IgG antibodies were determined by the ELISA method in residual serum samples obtained from subjects aged between 6 and 64 years and residing in 13 Italian regions. Overall, 3746 serum samples were collected in the years 2019 and 2020. The overall seroprevalence was 91.6% (89.9% in males and 93.3% in females; p = 0.0002). Seroprevalence showed an increasing trend (p < 0.0001) starting in the younger age groups: 6–9 years: 84.1%; 10–14 years: 88.7%; 15–19 years: 89.3%; 20–39 years: 93.1% and >40 years: 97.0%. The seroprevalence data obtained in the present study were compared with those relating to previous sero-epidemiological surveys conducted, respectively, in the years 1996–1997, 2003–2004 and 2013–2014, taking into consideration only data from regions monitored in all surveillance campaigns. The comparison highlighted for the period 2019–2020 showed significantly higher values in the age groups 6–9 (p < 0.001), 10–14 (p = 0.018) and 15–19 years (p = 0.035), while in adults, the trend did not change over time (ns). These results highlight the positive impact of varicella vaccination in Italy.

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results